【摘 要】
:
OBJECTIVE Since cyclic AMP (cAMP) signaling cascade has been implicated in mediating behavioral responses to alcohol, key components in this cascade may serve as potential treatment targets.Phosphodie
【机 构】
:
National Institute on Drug Dependence, Peking University, Beijing 100000, China
论文部分内容阅读
OBJECTIVE Since cyclic AMP (cAMP) signaling cascade has been implicated in mediating behavioral responses to alcohol, key components in this cascade may serve as potential treatment targets.Phosphodiesterase 4 (PDE4), an enzyme that specifically catalyzes the hydrolysis of cAMP, plays a critical role in regulating its intracellular levels.Thus, it was of interest to determine whether PDE4 was involved in the regulation of alcohol use and abuse.METHODS Male Fawn-Hooded (FH/Wjd) rats were tested for 5% (V/V) ethanol and 10% (W/V) sucrose operant oral serf-administration following treatment with the selective PDE4 inhibitor rolipram (0.0125,0.025, and 0.05 mg·kg-1 , s.c.) ; rolipram at higher doses (0.05,0.1, and 0.2 mg·kg-1 , s.c.) was tested to determine its impact on the intake of ethanol, sucrose, or water using the two-bottle choice drinking paradigm.Subsequent open-field testing was performed to evaluate the influence of higher doses of rolipram on locomotor activity.RESULTS Acute administration of rolipram dose-dependently reduced operant self-administration of 5% ethanol, but had no effect on 10% sucrose responding.Time-course assessment revealed a significant anti-drinking effect of rolipram (0.1 and 0.2 mg·kg-1) in continuous-and intermittent-access to ethanol at 5% or 10%, respectively.Moreover, chronic rolipram treatment time-dependently decreased 5% ethanol consumption and preference during treatment days and after the termination of rolipram administration.Rolipram at the highest doses (0.1 and 0.2 mg· kg-1) did decrease locomotor activity, but the effect lasted only 10 and 20 rain, respectively, which did not likely alter long-term ethanol drinking.CONCLUSION These results suggest that PDF4 plays a role in alcohol seeking and consumption behavior.Drugs interfering with PDE4 may be a potential pharmacotherapy for alcohol dependence.
其他文献
OBJECTIVE The present study was desighed to determine the causative links and precise correlations among microglial activation, the ATP-gated P2X7 purinergic receptor cation channel, and neuronal dege
OBJECTIVE The present study was desighed to determine the causative links and precise correlations among nitrosative stress, the cellular autophagy-lysosome process, and neurovascular damage during ce
The present study tested the hypothesis that induction of autophagy by producing appropriate amount of ER stress and autophagy activation is associated with neuroprotection in a rat model of focal cer
OBJECTIVE Comparative evaluations of cellular toxicity, lipophilicity and in vitro transmembrane transport of eight cerebrovascular protection flavonoids including puerarin, rutin, hesperidin, quercet
目的 膀胱过度活动症(OAB)严重影响患者生活质量,目前发病机理尚不清楚,本文研究了多胺在OAB发病机制中的作用.方法 临床获取人OAB和对照组膀胱上皮组织并进行组织培养,在培养的膀胱上皮细胞(BUC)上,利用高压液相检测多胺(腐胺,亚精胺,精胺)的细胞内水平,特异性抑制多胺合成酶后对多胺水平的影响;细胞内显微测钙技术和酶联免疫吸附试验(ELISA)分别观察多胺对胆碱能受体激动诱导的BUC内钙动员
任何新药研究都应采用合适的模型、方法,要求达到灵敏、客观、可重复,符合国际标准,能跟上当前世界上普遍接受的理论学说。目前我国神经药理研究中开展较为普遍的两项研究是认知研究和脑卒中研究。这两项研究多数尚部够规范,技术方法未跟上国际发展趋势,现提出来跟同行讨论切磋。
OBJECTIVE Compound FLZ is a novel synthetic squamosamide cyclic analogue with several phenolichydroxy groups.Previous researches have demonstrated that FLZ exhibits strong anti-oxidative and neuroprot
目的 观察丹酚酸A(salvianolic acid A,SalA)对1型糖尿病大鼠周围神经病变是否有保护作用及可能的机制.方法 雄性SD大鼠,链脲佐菌素(STZ) 60 mg·kg-1,腹腔注射,一周后测血糖,空腹血糖>11 mmol·L-1为糖尿病模型造模成功,血糖升高4周后,根据血糖和周围神经症状随机分组,分为正常组、糖尿病周围神经病变模型组、阳性药依帕司他(epalrestat)组、丹酚酸
目的 AQP4是一种水通道蛋白,广泛表达于脑内星形胶质细胞,其主要功能是维持脑内水的稳态.最近发现AQP4也参与调节胶质细胞的功能,而胶质细胞除了对神经元其支撑作用外,还参与调节突触可塑性.本文研究了AQP4对杏仁核突触可塑性和恐惧记忆的影响及机制,以期发现AQP4新的病理生理功能.方法 采用场电位技术记录AQP4野生(WT)鼠和敲除(KO)鼠离体脑片杏仁核的LTP;采用行为学方法测试WT鼠和KO
目的 采用Moms水迷宫检测小鼠空间学习记忆和记忆保持能力,评价姜黄素对APP/PS1双转基因小鼠认知功能的影响;并观察姜黄素对APP/PS1双转基因小鼠以及海马葡萄糖转运子1(glucose transporter 1,GLUT1)和葡萄糖转运子3(GLUT3)表达的影响,从脑能量代谢的角度探讨姜黄素神经保护作用的机制.方法 将3月龄的APP/PS1双转基因小鼠随机分为模型组、罗格列酮组、姜黄素